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This study examined the effects of prior upper body exercise on subsequent high-intensity 25 
cycling exercise tolerance and associated changes in neuromuscular function and perceptual 26 
responses. Eight males performed 3 fixed work-rate (85% peak power) cycling tests: (1) to 27 
the limit of tolerance (CYC); (2) to the limit of tolerance after prior high-intensity arm-28 
cranking exercise (ARM-CYC); (3) without prior exercise and for an equal duration as ARM-29 
CYC (ISOTIME). Peripheral fatigue was assessed via changes in potentiated quadriceps 30 
twitch force during supramaximal electrical femoral nerve stimulation. Voluntary activation 31 
was assessed using twitch interpolation during maximal voluntary contractions. Cycling time 32 
during ARM-CYC and ISOTIME (4.33  1.10 min) was 38% shorter than CYC (7.46  2.79 33 
min) (P < 0.001). Twitch force decreased more after CYC (-38  13%) than ARM-CYC (-26 34 
 10%) (P = 0.004) and ISOTIME (-24  10%) (P = 0.003). Voluntary activation was 94  5% 35 
at rest and decreased after CYC (89  9%, P = 0.012) and ARM-CYC (91  8%, P = 0.047). 36 
Rating of perceived exertion for limb discomfort increased more quickly during cycling in 37 
ARM-CYC (1.83  0.46 AUmin-1) than CYC (1.10  0.38 AUmin-1, P = 0.003) and 38 
ISOTIME (1.05  0.43 AUmin-1, P = 0.002), and this was correlated with the reduced 39 
cycling time in ARM-CYC (r = -0.72, P = 0.045). In conclusion, cycling exercise tolerance 40 
after prior upper body exercise is potentially mediated by central fatigue and intolerable 41 








A consistent reduction (35%) in the potentiated quadriceps twitch force is observed 48 
after high-intensity cycling (4-6, 66, 73, 79). It is proposed that this reduction represents an 49 
“individual critical threshold” of peripheral locomotor muscle fatigue beyond which the 50 
degree of associated sensory perception would not be tolerable (3). The observation of similar 51 
intramuscular metabolic perturbation at the end of exhaustive exercise irrespective of the 52 
work-rate (20, 77) supports the notion that it is probably not peripheral fatigue per se that is 53 
monitored / regulated but the associated fatigue-inducing biochemical changes within the 54 
muscle (3). The critical limit of peripheral fatigue observed under “normal” conditions is also 55 
unchanged when exercise tolerance is reduced (i.e. the critical limit is reached more quickly) 56 
due to moderate hypoxia (FIO2 0.13-0.15) (7, 66), superimposed inspiratory muscle loading 57 
(67), volitionally-induced inspiratory or expiratory muscle fatigue (73, 80), prior high-58 
intensity cycling exercise (5), and prior electrically-induced quadriceps muscle fatigue (34). 59 
Conversely, the degree of peripheral fatigue observed after cycling exercise in severe hypoxia 60 
(FIO2 0.10) is about two-thirds of that observed in normoxia, suggesting that the major 61 
determinant of exercise tolerance switches from a peripheral to central origin, possibly due to 62 
brain hypoxia (8). Individual critical limits to peripheral fatigue are thought to be mediated 63 
by thin fiber group III/IV muscle afferents (3, 31), which may influence central motor drive, 64 
and thereby exercise tolerance, by providing inhibitory feedback to the central nervous 65 
system in response to intramuscular metabolic perturbation (1, 10, 25, 51). However, despite 66 
growing support for an important role of peripheral fatigue in determining exercise tolerance, 67 
this notion has been challenged (53, 54). Marcora (53) has proposed a psychobiological 68 
model of endurance exercise tolerance, which primarily attributes exercise intolerance to a 69 
conscious decision to stop exercise due to perception of effort, mediated exclusively by feed-70 
forward mechanisms (i.e. corollary discharge), reaching a level that the individual is 71 
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unwilling to tolerate. A pivotal role for the rating of perceived exertion (RPE) in limiting 72 
exercise tolerance is also depicted in the ‘flush model’ proposed by Millet (57). However, 73 
this model differs from the psychobiological model because it attributes RPE to both feed-74 
forward and feedback (i.e. peripheral) mechanisms, thereby also emphasizing the importance 75 
of intramuscular metabolic perturbation and peripheral fatigue. The importance of sensory 76 
perception in influencing exercise tolerance is also evident in the striking ability of the RPE 77 
to predict the tolerable duration of exercise after prior fatiguing exercise (32), and at various 78 
exercise intensities (64), muscle glycogen concentrations (59) and ambient temperatures (24). 79 
Thus the rate of increase in RPE (ΔRPE/Δtime), and possibly dyspnea (Δdyspnea/Δtime), 80 
may be considered major contributors to the attainment of a “critical sensory tolerance limit” 81 
(35, 57) and subsequent cessation of exercise.  82 
Several studies have also shed light on the determinants of exercise tolerance by 83 
showing reduced lower body exercise tolerance after prior high-intensity upper body exercise 84 
(12, 17, 36, 44, 46, 47, 61). This has been attributed to an accelerated development of 85 
peripheral locomotor muscle fatigue secondary to faster intramuscular metabolite (i.e. K+, H+, 86 
and La-) accumulation resulting from the prior upper body exercise. However, this 87 
explanation remains conjecture because peripheral fatigue was not evaluated in these studies. 88 
An alternative explanation is that rather than accelerating the development of peripheral 89 
fatigue, prior upper body exercise might reduce lower body exercise tolerance by accelerating 90 
the attainment of an intolerable level of sensory perception that is mediated, in part, by the 91 
ensemble input of group III/IV muscle afferents. Specifically, since group III/IV muscle 92 
afferent input may remain elevated for up to 15 min after high-intensity upper body exercise 93 
(25, 45), the ensemble group III/IV muscle afferent input would be elevated during 94 
subsequent high-intensity lower body exercise. Subsequently, increases in ΔRPE/Δtime 95 
and/or Δdyspnea/Δtime may reduce exercise tolerance with less lower body peripheral 96 
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fatigue incurred. This notion is supported by the observation of increased RPE and reduced 97 
exercise tolerance with less peripheral fatigue incurred during single-leg knee extensor 98 
exercise preceded by fatiguing knee extensor exercise using the contralateral leg (10).  99 
Therefore, the present study aimed to elucidate the mechanism(s) by which prior 100 
high-intensity upper body exercise reduces subsequent leg cycling exercise tolerance. 101 
Specifically, we tested the hypothesis that prior upper body exercise reduces subsequent leg 102 
cycling exercise tolerance and that this is associated with less peripheral fatigue, but an 103 
accelerated rise in ΔRPE/Δtime and Δdyspnea/Δtime . 104 
METHODS 105 
Participants 106 
Eight healthy, non-smoking, moderately trained males (age: 26  4 years; height: 182 107 
 4 cm; body mass: 83  4 kg; peak oxygen uptake: 50  10 mLkg-1min-1) provided written 108 
informed consent to participate in the study. Five of the participants had previously taken part 109 
in investigations that included assessment of neuromuscular function using the methods 110 
described in the present study (38-41). Participants refrained from strenuous exercise and 111 
alcohol the day preceding and the day of an exercise test, abstained from caffeine on test 112 
days, and reported to the laboratory at least 2 h post-prandial. The study was approved by the 113 
Nottingham Trent University Human Ethics Committee, and all procedures were conducted 114 
in accordance with the Declaration of Helsinki. 115 
Experimental design 116 
Participants attended the laboratory on five separate occasions, at a similar time of 117 
day, separated by at least 48 h. The initial visit comprised a maximal incremental cycling test 118 
for the determination of peak oxygen uptake and peak cycling power (
peakW
 ). The second 119 
visit comprised familiarization with the knee extensor neuromuscular function assessments 120 
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and arm-cranking protocol. The subsequent three visits comprised the experimental trials. 121 
The first two experimental trials were performed in a randomized order and comprised a 122 
fixed work-rate cycling test at 85% ,Wpeak
  and exercise was performed to the limit of 123 
tolerance. These two cycling tests were performed without (hereafter termed CYC) and with 124 
(hereafter termed ARM-CYC) prior high-intensity arm-cranking exercise. For the third 125 
experimental trial, the CYC protocol was repeated except that the cycling test was terminated 126 
after an identical duration to that achieved during ARM-CYC (hereafter termed ISOTIME). 127 
Knee extensor force and surface electromyographic (EMG) signals were recorded during a 128 
series of electrically-evoked and voluntary isometric contractions of the dominant leg to 129 
quantify the presence and magnitude of central and peripheral locomotor muscle fatigue. For 130 
an illustration of the protocol for the experimental trials please refer to Figure 1. 131 
Neuromuscular Function 132 
Dynamometer Participants were seated in a rigid, custom built dynamometer adapted from 133 
Hannah et al. (40), with hip and knee joint angles of 100° and 95° (180° = full extension) 134 
respectively. Adjustable strapping across the pelvis and shoulders prevented extraneous 135 
movement during muscle activation. A non-compliant strap was attached to the dominant leg 136 
of the participant ~2 cm proximal to the medial malleolus and was in series with a linear 137 
strain gauge (615, Tedea-Huntleigh, Herzliya, Israel) oriented perpendicular to the tibia. The 138 
dynamometer configuration was established during the familiarization session and replicated 139 
thereafter. The force signal was amplified (×1000) in the frequency range 0-500 Hz, and 140 
sampled at 2000 Hz using an external A/D converter (1401; CED, Cambridge, UK) 141 
interfaced with a personal computer using Spike 2 software (CED). Force data were low-pass 142 
filtered in both directions at 450 Hz using a fourth-order zero-lag Butterworth filter prior to 143 
analysis. Baseline resting force was subtracted from all force recordings to correct for the 144 
effect of gravity. 145 
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Electromyography EMG signals were recorded from the superficial quadriceps (rectus 146 
femoris, vastus medialis, and vastus lateralis) and hamstring (biceps femoris) muscles, as 147 
described previously (40). After preparation of the skin by shaving, light abrasion, and 148 
cleaning with alcohol, bipolar surface electrodes (2.5 cm inter-electrode distance; silver/silver 149 
chloride, 95 mm2 area, Ambu Blue Sensor; Ambu, Ballerup, Denmark) were attached over 150 
each muscle at standardized percentages of thigh length measured from the knee joint space 151 
to the greater trochanter (rectus femoris, 55%; vastus medialis, 25%; vastus lateralis and 152 
biceps femoris, 45%). These sites were selected to avoid the innervation zones of each 153 
muscle (65). Electrodes were positioned parallel to the presumed orientation of the muscle 154 
fibers. EMG signals were pre-amplified by active EMG leads (input impedance 100 MΩ, 155 
common mode rejection ratio > 100 dB, base gain 500, 1st order high pass filter set to 10 Hz; 156 
Noraxon, Scottsdale, USA) connected in series to a custom-built junction box and 157 
subsequently to the same A/D converter and computer software that enabled synchronization 158 
with the force data. The signals were sampled at 2000 Hz. Prior to analysis EMG data were 159 
band-pass filtered in both directions between 20 and 450 Hz using a fourth-order zero-lag 160 
Butterworth filter (26, 27, 55).  161 
Electrical stimulation Equipment and procedures for electrical stimulation have been 162 
described previously (41). A constant current variable voltage stimulator (DS7AH; Digitimer 163 
Ltd, Welwyn Garden City, UK) was used to assess knee extensor contractile properties whilst 164 
the participant was voluntarily passive. Square-wave pulses (0.2 ms duration) were delivered 165 
via supramaximal femoral nerve stimulation to evoke maximal potentiated twitch and triplet 166 
(3 pulses at 300 Hz) contractions (24, 41). Stimulation of the femoral nerve was achieved via 167 
a 1 cm diameter cathode stimulation probe (Electro Medical Supplies, Wantage, UK) pressed 168 
into the femoral triangle. The surface of the anode, a 4  7 cm carbon rubber electrode 169 
(Electro Medical Supplies), was coated in electrode gel and located over the greater 170 
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trochanter. The precise location of the cathode was determined as the position that evoked the 171 
greatest twitch response for a particular submaximal electrical current (typically 30–50 mA), 172 
and was marked on the skin using indelible ink to ensure accurate repositioning within each 173 
trial.  174 
Procedure Initially discrete electrical stimuli were delivered via percutaneous stimulation of 175 
the femoral nerve in the femoral triangle to elicit twitch contractions of the quadriceps. 176 
Stepwise increments in the current were delivered, separated by 10 s to allow for 177 
neuromuscular recovery, until plateaus were reached in the amplitude of twitch force and 178 
compound muscle action potentials (M-waves). The stimulus intensity was then increased by 179 
25% above the value required to elicit a plateau to ensure supramaximal stimulation. 180 
Participants subsequently performed sub-maximal warm-up contractions of the knee 181 
extensors, lasting ~3 s and interspersed by ~30 s rest, at ~50, 75 and 90% of their perceived 182 
maximal force. Thereafter, and following baseline measurements for heart rate and [La-]B, 183 
participants performed four maximum voluntary contractions (MVCs) lasting 3-4 s and 184 
interspersed by ~30 s rest. Participants were instructed to extend the knee “as hard and as fast 185 
as possible”. During and after each contraction participants received strong verbal 186 
encouragement. Online feedback of the force signal was provided and a marker showing 187 
maximum force during that session was displayed onscreen in order to assist participants in 188 
attempting to maintain a high and stable force level. Each MVC was followed within 1-2 s by 189 
two supramaximal electrical stimuli, separated by 1 s, delivered to the femoral nerve to elicit 190 
maximal potentiated twitches (49). Single electrically-evoked triplet contractions (3 191 
supramaximal stimuli delivered at 300 Hz) were superimposed on the 3rd and 4th MVC, and at 192 
rest ~1-2 s after the two potentiated twitch contractions (29, 48). Triplets were used in the 193 
calculation of voluntary activation (see below), because the detection of single superimposed 194 
twitches becomes increasingly difficult at high forces as a result of the decreasing signal-to-195 
9 
 
noise ratio. This may lead to the erroneous conclusion that voluntary activation is maximal 196 
(i.e. 100%). Consequently, some studies have suggested the use of multiple stimuli (48, 63, 197 
72). Furthermore, triplets may offer advantages over potentiated twitches as an indicator of 198 
peripheral fatigue since pilot data from our lab and that of de Haan (28, 29) has found the 199 
force evoked by 300 Hz bursts (3-8 pulses) to be insensitive to potentiation, and because they 200 
evoke much greater force than potentiated twitches they may better reflect the functional 201 
changes observed during maximal voluntary contractions. 202 
The maximum voluntary force (MVF) of the quadriceps was defined as the greatest 203 
instantaneous force produced during the relevant series of MVCs. The root mean square 204 
(RMS) amplitude of the EMG signal for each agonist muscle (vastus medialis, vastus lateralis 205 
and rectus femoris) was calculated over a 500 ms epoch surrounding MVF (250 ms either 206 
side) (19). Agonist EMG RMS values were averaged to calculate a mean quadriceps 207 
(QEMGmax) value and normalized to the peak-to-peak amplitude of the M-wave (see below) 208 
to provide a measure of neuromuscular activation. Potentiated twitches were measured for 209 
peak force and the amplitude of M-wave response for the three quadriceps electrodes, which 210 
were then averaged across the three sites to provide a mean quadriceps value. Mean 211 
quadriceps M-wave amplitude and potentiated peak twitch force were averaged across the 212 
latter four twitch contractions (i.e. after the 3rd and 4th MVC) within each time period because 213 
it typically takes three MVC’s to fully potentiate twitches (49). The mean quadriceps M-wave 214 
amplitude across the four potentiated twitches was defined as the maximal M-wave amplitude 215 
(Mmax) and was used for normalization of voluntary quadriceps EMG RMS (19). Measures of 216 
triplet peak force were averaged across the two contractions within each time period. To 217 
evaluate the presence and magnitude of central fatigue voluntary activation was evaluated for 218 
the 3rd and 4th MVC using the formula for the twitch interpolation technique (56) as described 219 
previously (29, 48): 220 
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Voluntary activation (%) = 100 – [(triplet force increment / resting triplet force) × 100] 221 
where the triplet force increment refers to that produced by superimposed triplet stimulation. 222 
The highest voluntary activation of the two MVCs was retained for analysis. Assessment of 223 
neuromuscular function (from the first MVC to the last triplet) took 2 min.  224 
Maximal incremental cycling test 225 
Participants initially performed a maximal incremental cycling test using an 226 
electromagnetically-braked cycle ergometer (Excalibur Sport; Lode, Groningen, The 227 
Netherlands). Tests began at 0 W and power was increased by discrete 20 W increments 228 
every 60 s and exercise was performed to the limit of volitional tolerance or task failure (i.e. 229 
cycling cadence below 60 rpm) (46). Participants wore a facemask (model 7940; Hans 230 
Rudolph, Missouri, USA) connected to a flow sensor (ZAN variable orifice pneumotach; 231 
Nspire Health, Oberthulba, Germany) that was calibrated using a 3 L syringe. Gas 232 
concentrations were measured using fast responding laser diode absorption spectroscopy 233 
sensors, which were calibrated using gases of known concentration (5% CO2, 15% O2, 234 
balance N2; BOC, Guilford, UK), and ventilatory and pulmonary gas exchange variables were 235 
measured breath-by-breath (ZAN 600USB; Nspire Health) as described previously (46). Peak 236 
oxygen uptake was defined as the highest recorded value over any 30 s period, and 
peakW
  was 237 
calculated as the sum of the power output in the last completed stage plus the product of ramp 238 
increment (20 W) and the fraction of the final stage actually completed.  239 
Experimental trials 240 
During the experimental trials (CYC, ARM-CYC, and ISOTIME) heart rate was 241 
measured using short-range telemetry (Polar S610; Polar, Kempele, Finland) and fingertip 242 
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capillary blood samples were taken and analyzed for blood lactate concentration ([La-]B) 243 
using an automated analyzer (Biosen C_line Sport; EKF Diagnostics, Barleben, Germany).  244 
An illustration of the timing of measurements taken during the experimental trials is 245 
shown in Figure 1. Each experimental trial comprised a fixed work-rate cycling test at 85% 246 
peakW
  preceded by a standardized 23.5 min period. During the first 6 min of this period 247 
baseline measures of heart rate, [La-]B, and neuromuscular function were taken.  248 
After baseline measurements, participants remained seated in the dynamometer and 249 
then either rested (CYC and ISOTIME) or performed intense intermittent arm-cranking 250 
exercise (ARM-CYC) using an electromagnetically-braked arm-cranking ergometer (Angio; 251 
Lode). The arm-cranking protocol comprised 8  1 min arm-cranking bouts, interspersed with 252 
30 s rest, at a fixed work-rate of 1.0-1.5 Wkg-1 body mass (mean: 1.2  0.2 Wkg-1 body 253 
mass, 100  15 W) (46). As in our previous study (46), the arm-cranking work-rate for each 254 
individual was selected based on their habitual upper body exercise regimen. This work-rate 255 
was trialed during the familiarization session and, based on successful completion by all 256 
participants, was deemed suitable for subsequent testing. Cadence was maintained between 257 
90-110 rpm. Heart rate was measured at the end of each arm-cranking bout during ARM-258 
CYC, and [La-]B was also measured after the final arm-cranking bout. These measurements 259 
were taken at equivalent time points whilst participants rested during CYC and ISOTIME. 260 
Quadriceps and hamstring muscle EMG was recorded throughout the arm-cranking protocol 261 
and displayed online with a high gain to aid visual detection of EMG activity. Participants 262 
received verbal feedback regarding EMG activity in order to ensure minimal activation of the 263 
leg muscles.  264 
Arm-cranking (ARM-CYC) or seated rest (CYC and ISOTIME) was followed by 265 
another 6 min period before the start of the fixed work-rate cycling test. During this period 266 
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measures of neuromuscular function were taken and participants then transferred to the cycle 267 
ergometer (positioned 2 m from the dynamometer). Immediately before the start of the 268 
cycling test heart rate and [La-]B were measured along with dyspnea (defined as breathing 269 
“effort”) and RPE for leg discomfort using Borg’s modified CR10 scale (18).  270 
Participants adopted a self-selected cadence between 80-100 rpm during the first 271 
cycling test and this was replicated during subsequent tests. Quadriceps and hamstring 272 
muscle EMG was synchronized with the cycle ergometer crank position via a reed switch 273 
attached to the crank and ergometer. The RMS amplitude of the EMG signal of the 274 
quadriceps muscle was measured at the start and end of each minute during each arm-275 
cranking exercise bout and normalized to QEMGmax to quantify quadriceps neuromuscular 276 
activation. EMG RMS amplitude of the quadriceps and hamstring muscles was also measured 277 
over 10 consecutive pedal revolutions at the end of the first, third and final minute of cycling 278 
exercise and normalized to Mmax (quadriceps only) to quantify changes in neuromuscular 279 
activation during cycling. Onsets and offsets of EMG bursts were determined visually by the 280 
same investigator according to a previously published method (22, 23). Threshold methods 281 
for determining EMG onsets and offsets are sensitive to changes in background EMG (42) 282 
and are unsuitable for this type of analysis because bursts of EMG activity occur with 283 
background activity already present in the muscles and the amplitude of background activity 284 
varies between muscles (22, 23). Heart rate, RPE and dyspnea were measured after 3 min of 285 
cycling. During CYC and ARM-CYC, cycling exercise was performed to the limit of 286 
volitional tolerance. An additional criterion for terminating a cycling test was a fall in 287 
cadence below 60 rpm. During ISOTIME, cycling exercise was terminated by the 288 
investigators after an identical duration to that achieved during ARM-CYC.  289 
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Upon cessation of cycling exercise heart rate, [La-]B, RPE and dyspnea were 290 
measured immediately and participants were assisted to the dynamometer for neuromuscular 291 
function evaluation with the first MVC initiated after 2 min ( 9 s).  292 
Statistical analyses 293 
Data were analyzed using SPSS for Windows (IBM, Chicago, IL). Trial-to-trial 294 
variation in baseline neuromuscular function was calculated as the within-participant 295 
coefficient of variation (CV). Measurement error and reproducibility of baseline 296 
neuromuscular function were calculated, and the smallest meaningful change was 297 
subsequently determined (16, 43). A one-way repeated measures ANOVA followed by 298 
Tukey’s post-hoc test was used to analyze differences between trials for cycling exercise 299 
duration and rates of change in perceptual responses expressed relative to absolute exercise 300 
time (ΔRPE/Δtime and Δdyspnea/Δtime) and when normalized to total cycling exercise 301 
duration (ΔRPE/%time and Δdyspnea/%time). All other data were analyzed using a two-way 302 
(trial  time) repeated measures ANOVA. Significant interactions were further explored by 303 
performing one-way repeated measures ANOVA: (i) within each trial, and (ii) across trials at 304 
individual time-points, followed by Tukey’s post-hoc test. When differences were observed 305 
within or between trials, 95% confidence intervals (CI) for the difference were calculated (2). 306 
Pearson’s correlation coefficient was used to determine the relationship between selected 307 
variables. Statistical significance was set at P < 0.05. Results are presented as mean  SD.  308 
RESULTS 309 
Cycling exercise tolerance 310 
There was an effect of trial on cycling exercise duration at 85% 
peakW
  (273  26 W) 311 
[F(2,14) = 16.8, P < 0.001], which was, as expected, identical (4.33  1.10 min) during 312 
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ARM-CYC and ISOTIME and 38  17% shorter than CYC (7.46  2.79 min) (mean 313 
difference = 3.13  2.15 min, 95% CI = 1.50 to 4.75 min, P < 0.001). Cycling cadence at the 314 
termination of cycling exercise in CYC (68  6 rpm, range: 61-78 rpm), ARM-CYC (66  5 315 
rpm, range: 60-74 rpm) and ISOTIME (92  10 rpm, range: 85-104 rpm) was always ≥60 316 
rpm. Therefore, cycling exercise during CYC and ARM-CYC was always performed to the 317 
limit of volitional tolerance rather than being terminated by the investigators.  318 
Neuromuscular function 319 
Baseline measures of neuromuscular function are shown in Table 1 and these were 320 
highly reproducible between trials. Raw traces of force from a representative participant at 321 
baseline performing a MVC with superimposed triplet, followed by twitch and triplet 322 
contractions, are shown in Figure 2. In all trials measures of neuromuscular function were 323 
unchanged from baseline to pre-cycling (data not shown). Thus arm-cranking per se did not 324 
result in central or peripheral locomotor muscle fatigue.  325 
For MVF, there was a trial  time interaction [F(4,28) = 6.2, P < 0.001] and an effect 326 
of time in CYC [F(2,14) = 14.3, P < 0.001], ARM-CYC [F(2,14) = 11.5, P = 0.001] and 327 
ISOTIME [F(2,14) = 8.5, P = 0.003]. MVF decreased from baseline to post-cycling in CYC 328 
(mean difference = 95  70 N, 95% CI = 45 to 145 N, P < 0.001), ARM-CYC (mean 329 
difference = 56  39 N, 95% CI = 22 to 89 N, P = 0.002) and ISOTIME (mean difference = 330 
49  48 N, 95% CI = 13 to 85 N, P = 0.008). Furthermore, there was an effect of trial on the 331 
decrease in MVF [F(2,14) = 8.3, P = 0.004], which was greater in CYC than ARM-CYC 332 
(mean difference = 39  38 N, 95% CI = 7 to 71 N, P = 0.02) and ISOTIME (mean difference 333 
= 46  43 N, 95% CI = 14 to 78 N, P = 0.005) (Fig. 3A).  334 
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For voluntary activation, there was a trial  time interaction [F(4,28) = 3.8, P = 0.013] 335 
and an effect of time in CYC [F(2,14) = 8.0, P = 0.005] and ARM-CYC [F(2,14) = 4.7, P = 336 
0.027], but not ISOTIME [F(2,14) = 0.8, P = 0.46]. Voluntary activation decreased from 337 
baseline (see Table 1) to post-cycling in CYC (89  9%, mean difference = 5.0  4.8%, 95% 338 
CI = 1.4 to 8.7%, P = 0.012) and ARM-CYC (91  8%, mean difference = 3.8  4.7%, 95% 339 
CI = 0.1 to 7.4%, P = 0.047). Furthermore, there was an effect of trial on the decrease in 340 
voluntary activation [F(2,14) = 5.2, P = 0.021], which was greater in CYC than ISOTIME 341 
(mean difference = 4.4  4.9%, 95% CI = 0.7 to 8.0%, P = 0.019) (Fig. 3B).  342 
For potentiated twitch force, there was a trial  time interaction [F(4,28) = 8.8, P < 343 
0.001] and an effect of time in CYC [F(2,14) = 49.4, P < 0.001], ARM-CYC [F(2,14) = 48.3, 344 
P < 0.001], and ISOTIME [F(2,14) = 22.7, P < 0.001]. Potentiated twitch force decreased 345 
from baseline to post-cycling in CYC (mean difference = 77  30 N, 95% CI = 55 to 98 N, P 346 
< 0.001), ARM-CYC (mean difference = 52  21 N, 95% CI = 38 to 66 N, P < 0.001) and 347 
ISOTIME (mean difference = 50  24 N, 95% CI = 30 to 70 N, P < 0.001). Furthermore, 348 
there was an effect of trial on the decrease in potentiated twitch force [F(2,14) = 10.9, P = 349 
0.001], which was greater in CYC than ARM-CYC (mean difference = 25  17 N, 95% CI = 350 
8 to 41 N, P = 0.004) and ISOTIME (mean difference = 27  22 N, 95% CI = 10 to 43 N, P = 351 
0.003) (Fig. 3C).  352 
For potentiated triplet force, there was a trial  time interaction [F(4,28) = 9.1, P < 353 
0.001] and an effect of time in CYC [F(2,14) = 11.1, P = 0.001], ARM-CYC [F(2,14) = 5.4, 354 
P = 0.018], and ISOTIME [F(2,14) = 7.2, P = 0.007]. Potentiated triplet force decreased from 355 
baseline to post-cycling in CYC (mean difference = 63  50 N, 95% CI = 26 to 100 N, P = 356 
0.001), ARM-CYC (mean difference = 37  40 N, 95% CI = 7 to 66 N, P = 0.014) and 357 
ISOTIME (mean difference = 31  26 N, 95% CI = 9 to 52 N, P < 0.001). Furthermore, there 358 
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was an effect of trial on the decrease in potentiated triplet force [F(2,14) = 9.0, P = 0.003], 359 
which was greater in CYC than ARM-CYC (mean difference = 27  18 N, 95% CI = 5 to 48 360 
N, P = 0.015) and ISOTIME (mean difference = 33  28 N, 95% CI = 11 to 54 N, P = 0.004). 361 
(Fig. 3D). 362 
Quadriceps Mmax and neuromuscular activation (i.e. RMS EMG normalized to Mmax) 363 
at MVF remained unchanged in all trials. 364 
Leg muscle EMG during cycling 365 
Quadriceps EMG RMS during arm-cranking was ≤3% of the QEMGmax during an 366 
MVC (data not shown), thus demonstrating minimal leg activation. For quadriceps 367 
neuromuscular activation (EMG RMS normalized to Mmax) during cycling, there was a trial  368 
time interaction [F(4,28) = 6.1, P = 0.001] and an effect of time in CYC [F(2,14) = 36.3, P < 369 
0.001], ARM-CYC [F(2,14) = 11.6, P = 0.001] and ISOTIME [F(2,14) = 36.3, P = 0.012]. 370 
There was also an effect of trial on neuromuscular activation in the final minute of cycling 371 
[F(2,14) = 6.2, P = 0.012], which was greater in CYC than ARM-CYC (mean difference = 372 
0.76  0.84 %Mmax, 95% CI = 0.03 to 1.5 %Mmax, P = 0.040) and ISOTIME (mean difference 373 
= 0.91  0.87 %Mmax, 95% CI = 0.18 to 1.64 %Mmax, P = 0.014). (Fig. 4). The absolute 374 
hamstrings EMG RMS remained constant during cycling and was not different between trials 375 
(pooled data: 0.08  0.05 mV). 376 
Heart rate and blood lactate concentration 377 
For heart rate, there was a trial  time interaction [F(24,168) = 81.7, P < 0.001] and 378 
an effect of trial on the mean of the eight heart rate measurements taken during the 11.5 min 379 
period of arm-cranking in ARM-CYC or seated rest in CYC and ISOTIME (see Fig. 1) 380 
[F(2,24) = 144.3, P < 0.001]. The mean heart rate during this period was higher in ARM-381 
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CYC (153  19 bpm) than CYC (72  14 bpm) (mean difference = 81  20 bpm, 95% CI = 382 
67 to 96 bpm, P < 0.001) and ISOTIME (73  11 bpm) (mean difference = 80  16 bpm, 95% 383 
CI = 66 to 95 bpm, P < 0.001). There was also an effect of trial on heart rate measured pre-384 
cycling [F(2,14) = 21.7, P < 0.001], after 3 min of cycling [F(2,14) = 17.8, P < 0.001], and 385 
post-cycling [F(2,14) = 12.3, P < 0.001]. Pre-cycling, heart rate was higher in ARM-CYC 386 
than CYC (mean difference = 34  21 bpm, 95% CI = 18 to 49 bpm, P < 0.001) and 387 
ISOTIME (mean difference = 34  15 bpm, 95% CI = 18 to 49 bpm, P < 0.001). After 3 min 388 
of cycling, heart rate was higher in ARM-CYC than CYC and ISOTIME (mean difference 389 
from both trials = 10  6 bpm, 95% CI = 5 to 15 bpm, P < 0.001). Post-cycling, heart rate 390 
was lower in ISOTIME than CYC (mean difference = 10  6 bpm, 95% CI = 3 to 16 bpm, P 391 
= 0.005) and ARM-CYC (mean difference = 12  8 bpm, 95% CI = 5 to 18 bpm, P = 0.001) 392 
(Fig. 5A).  393 
For [La-]B, there was a trial  time interaction [F(6,42) = 79.7, P < 0.001] and an 394 
effect of trial on [La-]B measured immediately after the period of arm-cranking in ARM-CYC 395 
or seated rest in CYC and ISOTIME [F(2,14) = 167.2, P < 0.001]. Immediately after this 396 
period, [La-]B was higher in ARM-CYC than CYC and ISOTIME (mean difference from both 397 
trials = 10.3  2.2 mmolL-1, 95% CI = 8.6 to 12.0 mmolL-1, P < 0.001). There was also an 398 
effect of trial on [La-]B measured pre-cycling [F(2,14) = 158.2, P < 0.001], which was higher 399 
in ARM-CYC than CYC (mean difference = 8.5  2.0 mmolL-1, 95% CI = 7.0 to 10.0 400 
mmolL-1, P < 0.001) and ISOTIME (mean difference = 8.6  1.8 mmolL-1, 95% CI = 7.2 to 401 
10.1 mmolL-1, P < 0.001). Furthermore, there was an effect of trial on [La-]B measured post-402 
cycling [F(2,14) = 31.9, P < 0.001], which was higher in ARM-CYC than CYC (mean 403 
difference = 2.3  1.0 mmolL-1, 95% CI = 0.8 to 3.9 mmolL-1, P = 0.003) and ISOTIME 404 
(mean difference = 4.6  1.8 mmolL-1, 95% CI = 3.1 to 6.1 mmolL-1, P < 0.001). Post-405 
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cycling, [La-]B was also higher in CYC than ISOTIME (mean difference = 2.3  2.0 mmolL-1, 406 
95% CI = 0.8 to 3.8 mmolL-1, P = 0.004) (Fig. 5B).  407 
Rating of perceived exertion and dyspnea 408 
There was a trial  time interaction for RPE [F(4,28) = 14.7, P < 0.001] and an effect 409 
of trial on RPE measured after 3 min of cycling [F(2,14) = 11.7, P = 0.001], which was 410 
higher in ARM-CYC than CYC (mean difference = 2.4  1.7 AU, 95% CI = 1.0 to 3.9 AU, P 411 
= 0.002) and ISOTIME (mean difference = 2.3  1.9 AU, 95% CI = 0.8 to 3.8 AU, P = 412 
0.003). There was also an effect of trial on RPE measured post-cycling [F(2,14) = 18.4, P < 413 
0.001], which was lower in ISOTIME than CYC (mean difference = 3.3  1.9 AU, 95% CI = 414 
1.4 to 5.2 AU, P = 0.001) and ARM-CYC (mean difference = 4.1  2.6 AU, 95% CI = 2.2 to 415 
5.9 AU, P < 0.001) (Fig. 6A). 416 
There was a trial  time interaction for dyspnea [F(4,28) = 5.8, P < 0.001] and an 417 
effect of trial on dyspnea measured after 3 min of cycling [F(2,14) = 16.3, P < 0.001], which 418 
was higher in ARM-CYC than CYC (mean difference = 1.9  1.4 AU, 95% CI = 0.9 to 3.0 419 
AU, P < 0.001) and ISOTIME (mean difference = 2.1  1.1 AU, 95% CI = 1.0 to 3.2 AU, P < 420 
0.001). There was also a main effect of trial on dyspnea measured post-cycling [F(2,14) = 421 
11.8, P = 0.001], which was lower in ISOTIME than CYC (mean difference = 2.8  2.4 AU, 422 
95% CI = 0.9 to 4.6 AU, P = 0.004) and ARM-CYC (mean difference = 3.1  2.6 AU, 95% 423 
CI = 1.3 to 5.0 AU, P = 0.002) (Fig. 6B).  424 
There was an effect of trial on ΔRPE/Δtime [F(2,14) = 11.7, P = 0.001], which was 425 
higher in ARM-CYC than CYC (mean difference = 0.72  0.63 AUmin-1, 95% CI = 0.25 to 426 
1.21 AUmin-1, P = 0.003) and ISOTIME (mean difference = 0.79  0.55 AUmin-1, 95% CI 427 
= 0.31 to 1.27 AUmin-1, P = 0.002) (Table 2). There was also an effect of trial on 428 
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Δdyspnea/Δtime [F(2,14) = 4.5, P = 0.031], which was higher in ARM-CYC than ISOTIME 429 
(mean difference = 0.46  0.58 AUmin-1, 95% CI = 0.02 to 0.90 AUmin-1, P = 0.038) (Table 430 
2).  431 
There was an effect of trial on ΔRPE/Δ%time [F(2,14) = 19.1, P < 0.001] (Fig. 6C 432 
and Table 2), which was lower in ISOTIME than CYC (mean difference = 0.03  0.01 433 
AU%time-1, 95% CI = 0.01 to 0.05 AU%time-1, P < 0.001) and ARM-CYC (mean 434 
difference = 0.04  0.02 AU%time-1, 95% CI = 0.02 to 0.05 AU%time-1, P < 0.001). There 435 
was also an effect of trial on Δdyspnea/Δ%time [F(2,14) = 7.5, P = 0.006] (Fig. 6D and Table 436 
2), which was lower in ISOTIME than CYC (mean difference = 0.03  0.01 AU%time-1, 95% 437 
CI = 0.01 to 0.05 AU%time-1, P = 0.006) and ARM-CYC (mean difference = 0.02  0.01 438 
AU%time-1, 95% CI = 0.001 to 0.04 AU%time-1, P = 0.036).  439 
When data from CYC and ARM-CYC were pooled, ΔRPE/Δtime was negatively 440 
correlated with the time to the limit of cycling exercise tolerance (r = -0.74, P = 0.001). 441 
Furthermore, the reduction in cycling exercise tolerance during ARM-CYC compared with 442 
CYC was negatively correlated with the increases in ΔRPE/Δtime (r = -0.72, P = 0.045) and 443 
Δdyspnea/Δtime (r = -0.80, P = 0.018). 444 
DISCUSSION 445 
The present study examined the effects of prior high-intensity upper body exercise on 446 
subsequent high-intensity leg cycling exercise tolerance and associated changes in 447 
neuromuscular function and perceptual responses. Our main findings were threefold: (I) prior 448 
upper body exercise in ARM-CYC reduced subsequent cycling exercise tolerance by 38%; (II) 449 
the reduced cycling exercise tolerance in ARM-CYC was associated with less peripheral 450 
muscle fatigue incurred but a similar reduction in voluntary activation compared with CYC; 451 
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and (III) the reduced cycling exercise tolerance in ARM-CYC was related to increases in 452 
ΔRPE/Δtime and Δdyspnea/Δtime. These findings suggest that exercise tolerance is not 453 
regulated by a critical level of peripheral fatigue. Instead, central fatigue and an exacerbation 454 
of perceptual responses are the potential mechanisms underlying the reduced cycling exercise 455 
tolerance after prior upper body exercise.  456 
We recently showed that high-intensity cycling exercise tolerance was reduced by a 457 
strikingly similar extent after an identical upper body exercise protocol (46). Several authors 458 
suggest that reduced lower limb exercise tolerance after prior upper body exercise occurs 459 
because of accelerated development of peripheral fatigue caused by greater intramuscular 460 
metabolic perturbation (12, 17, 36, 44, 46, 61). This notion is supported, indirectly, by the 461 
observation that prior high-intensity upper body exercise elevated leg muscle [La-] and [H+] 462 
at the onset of isolated knee extensor exercise (11, 12), accelerated the exercise-induced 463 
increase in interstitial [K+] (61), and reduced exercise tolerance (12, 61). However, although 464 
such metabolite accumulation has been implicated in the etiology of peripheral fatigue (21, 465 
33), previous prior upper body exercise studies did not measure peripheral fatigue or 466 
neuromuscular activation. Comparisons of our work with isolated knee extensor exercise 467 
studies are also complicated by the task-specificity of fatigue etiology (13, 74). Two 468 
observations from the present study suggest that peripheral fatigue during cycling exercise 469 
was not accelerated by prior upper body exercise. Firstly, the extent of peripheral fatigue in 470 
ARM-CYC and ISOTIME was the same even though there was considerable systemic 471 
metabolic perturbation in ARM-CYC. Indeed, in our previous study the same upper body 472 
exercise protocol reduced the strong ion difference by 15%, increased plasma [H+] by 33%, 473 
reduced ][HCO-3  by 29%, and accelerated the increase in plasma [K
+] during subsequent 474 
cycling exercise by 56% (46). Secondly, if peripheral fatigue during cycling exercise was 475 
accelerated this would be expected to result in greater neuromuscular activation (i.e. 476 
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increased motor unit recruitment and/or firing frequency) to compensate for the reduced force 477 
generating capacity (14, 30); however, this was not observed. Collectively, these observations 478 
therefore suggest that systemic metabolite perturbation plays a minor role in peripheral 479 
fatigue generation. 480 
 Our findings contrast previous cycling exercise studies in which moderate hypoxia (7, 481 
66), superimposed inspiratory muscle loading (67), volitionally-induced inspiratory or 482 
expiratory muscle fatigue (73, 80), prior high-intensity cycling exercise (5), and prior 483 
electrically-induced quadriceps muscle fatigue (34), reduced exercise tolerance but resulted 484 
in the same degree of peripheral fatigue incurred compared with control conditions. These 485 
observations are taken as evidence for inhibitory group III/IV muscle afferent feedback to the 486 
central nervous system regulating central motor drive to confine the development of 487 
peripheral fatigue to a critical threshold (3, 31). However, although the 38% reduction in 488 
twitch force after CYC is comparable to the proposed critical threshold of peripheral fatigue 489 
previously reported after high-intensity fixed work-rate cycling exercise (4, 5, 66, 73, 80), 490 
this degree of peripheral fatigue was not reached during ARM-CYC (26% reduction in twitch 491 
force). This finding is similar to the observation of less peripheral fatigue incurred after high-492 
intensity cycling exercise in severe hypoxia (FIO2 0.10) compared with normoxia (8). The 493 
notion that peripheral fatigue is not critically regulated is also supported by two recent 494 
isolated muscle studies: Rossman et al. (68) observed greater quadriceps muscle fatigue 495 
during single-leg compared with double-leg knee extensor exercise, whereas Amann et al. (10) 496 
observed less quadriceps muscle fatigue during single-leg knee extensor exercise after 497 
fatiguing knee extensor exercise with the contralateral leg. The present study thus extends 498 
these observations to whole-body exercise by providing novel evidence that peripheral 499 
fatigue is not independently regulated during high-intensity fixed work-rate cycling exercise 500 
to volitional tolerance. 501 
22 
 
Whether peripheral fatigue plays an important role in governing exercise tolerance 502 
remains controversial (9, 53, 54, 60). Consistent with previous observations (5, 7, 54, 71, 75), 503 
submaximal quadriceps muscle recruitment was observed at the limit of exercise tolerance in 504 
CYC and ARM-CYC (55% and 50%, respectively, of the QEMGmax) and Noakes (58) 505 
argues that this negates peripheral fatigue as the single limiting factor to exercise tolerance. 506 
Furthermore, Decorte et al. (30) have shown that peripheral fatigue during cycling exercise at 507 
80% Wpeak develops mostly during the first half of the test, such that the limit of tolerance 508 
approaches without further peripheral fatigue, but with a significant reduction in voluntary 509 
activation. The similar reduction in voluntary activation after CYC and ARM-CYC indicates 510 
that central fatigue developed more quickly in ARM-CYC, possibly due to a ‘spill-over’ of 511 
central fatigue from the exercised upper body muscles to the leg locomotor muscles. In 512 
support, it was recently demonstrated that fatiguing leg cycling exercise resulted in a ‘spill-513 
over’ of central fatigue (i.e. reduced voluntary activation) to the remote unexercised elbow 514 
flexors (69). This effect was attributed to inhibitory group III/IV muscle afferent feedback 515 
originating in fatigued leg muscle since attenuating this feedback using intrathecal fentanyl 516 
abolished the decline in voluntary activation of the elbow flexors. Whether a fall in voluntary 517 
activation limits cycling exercise that is characterized by submaximal muscle contractions 518 
remains uncertain (74). However, it is also recognized that a limiting influence of central 519 
fatigue on exercise tolerance may be manifest by changes in sensory perception (57, 74).   520 
The conscious perception of fatigue is thought to reflect the complex integration and 521 
interpretation of central motor drive and an associated corollary discharge, somatosensory 522 
feedback (4, 50, 70, 78), and cognitive functions such as motivation and emotional state (70). 523 
After 3 min of cycling, RPE for leg discomfort was greater in ARM-CYC compared with 524 
CYC and ISOTIME despite similar levels of quadriceps neuromuscular activation, which 525 
supports observations made during single-leg knee extensor exercise after fatiguing knee 526 
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extensor exercise with the contralateral leg (10). Furthermore, at the end of cycling, RPE was 527 
greater in ARM-CYC compared with ISOTIME despite similar levels of peripheral fatigue 528 
incurred, whereas RPE was similar at the end of cycling in CYC and ARM-CYC despite less 529 
peripheral fatigue incurred during ARM-CYC. Collectively, our findings suggest that the 530 
perception of leg discomfort during cycling exercise does not exclusively reflect the extent of 531 
quadriceps neuromuscular activation or degree of peripheral fatigue incurred. Similar 532 
observations have been made in COPD patients who sometimes stop exercise because of leg 533 
discomfort and in the absence of quadriceps muscle fatigue (52). These observations suggest 534 
that the conscious perception of leg discomfort likely reflects a complex interplay between 535 
multiple factors other than peripheral fatigue and neuromuscular activation (70). Minute 536 
ventilation was not measured in the present study and thus it cannot be ruled out that the 537 
greater Δdyspnea/Δtime during ARM-CYC resulted, in part, from a greater ventilatory 538 
response (10). However, afferents involved in the perception of dyspnea and limb discomfort 539 
project to the same sensorimotor brain areas (62) and, therefore, a heightened level of one 540 
perception may potentiate the other. In support, quadriceps fatigue induced by sustained 541 
contractions increased dyspnea during a subsequent inspiratory loaded breathing challenge 542 
without affecting breathing pattern or pleural pressure swings (37). Thus although we could 543 
not elucidate the precise causative mechanism(s), we propose that the greater ΔRPE/Δtime 544 
and Δdyspnea/Δtime during ARM-CYC reflects, in part, greater ensemble group III/IV 545 
afferent projections to integrated sensorimotor brain structures due to cycling commencing 546 
with pre-existing afferent input originating from the previously exercised respiratory (50) and 547 
upper body musculature (10, 25, 45), lungs (50), and heart (78). During cycling exercise the 548 
pre-existing afferent input would have been added to the prevailing inputs related to central 549 
motor drive, and locomotor muscle (10) and cardiorespiratory (50, 78) activity, thereby 550 
accelerating the increase in perceptual responses and reducing exercise tolerance. The 551 
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correlation between increased ΔRPE/Δtime and Δdyspnea/Δtime and reduced cycling 552 
exercise tolerance in ARM-CYC also supports sensory perception as an important mediator 553 
of exercise tolerance. Our findings are therefore consistent with the ‘flush model’ proposed 554 
by Millet (57), which suggests that exercise tolerance is mediated primarily by ΔRPE/Δtime 555 
which, in turn, depends mainly on feedback (i.e. peripheral) and feed-forward (i.e. central) 556 
mechanisms.  557 
The greater ΔRPE/Δtime and Δdyspnea/Δtime during ARM-CYC compared with 558 
CYC, but similar ΔRPE/Δ%time and Δdyspnea/Δ%time, suggests that the pre-existing 559 
afferent input at the onset of cycling in ARM-CYC affected perceptual responses by 560 
increasing their gain. Similar effects on the absolute and normalized RPE are observed when 561 
exercise tolerance is reduced by muscle glycogen depletion (59), warm and cold ambient 562 
temperatures (24), and prior fatiguing activity using the same muscle groups (32). These 563 
observations underpin the notion that perceptual responses are set in anticipation, otherwise 564 
known as teleoanticipation (76), so that exercise terminates at a critical sensory tolerance 565 
limit (32, 58, 60, 75). By limiting exercise tolerance the sensory tolerance limit will, therefore, 566 
also mediate the degree of peripheral fatigue incurred, which is consistent with the findings 567 
of recent studies using the isolated knee extensor exercise model (10, 68). We note, however, 568 
that the limit of cycling exercise tolerance during CYC and ARM-CYC was sometimes 569 
associated with submaximal RPE and dyspnea, suggesting that additional influences, such as 570 
psychological factors (15, 54), were also mediating the limit of exercise tolerance. 571 
In conclusion, reductions in cycling exercise tolerance due to prior upper body 572 
exercise are associated with an acceleration of central fatigue and greater perceptual 573 
responses rather than an accelerated development of peripheral fatigue. These findings 574 
suggest that peripheral fatigue is not independently regulated during high-intensity fixed 575 
work-rate cycling exercise to volitional tolerance, and that exercise tolerance, and thus the 576 
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degree of peripheral fatigue incurred, is potentially determined by intolerable levels of 577 
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 803 
Table 1. Baseline neuromuscular function and between-trial reproducibility. Measured 804 
variables are shown as mean  SD. CV, coefficient of variation; SMC, smallest meaningful 805 
change.  806 
 







MVF (N) 616  75 602  84 616  73 4 19 53 27 
Potentiated twitch force (N) 201  33 200  20 203  22 3 11 29 15 
Potentiated triplet force (N) 339  35 328  37 337  33 3 10 28 14 
Voluntary activation (%) 94  5 95  6 94  6 2 1.8 5.1 2.6 
Quadriceps M-wave amplitude (mV) 6.3  2.1 6.1  1.9 5.8  2.5 10 0.6 1.7 0.8 
Quadriceps EMG RMS at MVF 
(%Mmax amplitude) 
8.8  2.9 8.5  2.9 8.9  2.5 11 1.0 2.7 1.3 
MVF, maximal voluntary force.  807 
 808 
Table 2. Rates of change in the rating of perceived exertion (RPE) and dyspnea expressed 809 
relative to absolute exercise time and when normalized to total cycling exercise duration. 810 
Data are mean  SD.  811 
 CYC ARM-CYC ISOTIME 
ΔRPE/Δtime (AUmin-1) 1.10  0.38 1.83  0.46** 1.05  0.43 
ΔRPE/Δ%time (AU%time-1) 0.07  0.02 0.08  0.02 0.04  0.02** 
Δdyspnea/Δtime (AUmin-1) 0.93  0.39 1.33  0.55* 0.87  0.03 
Δdyspnea/Δ%time (AU%time-1) 0.07  0.03 0.06  0.02 0.04  0.02#† 
**P < 0.01 vs. other two trials; *P < 0.05 vs. ISOTIME; #P < 0.01 vs. CYC; †P < 0.05 vs. 812 






Fig. 1. Experimental protocol. Arrows denote timing of measurement. Note that [La-]B, heart 817 
rate, rating of perceived exertion (RPE) and dyspnea were measured immediately before the 818 
start of leg cycling exercise.  819 
 820 
 821 
Fig. 2. Raw traces of force at baseline from a representative participant. Force was measured 822 
during a maximal voluntary contraction with superimposed triplet, and subsequently during 823 
two potentiated twitch contractions and one triplet contraction. Inset figure provides a close 824 










Fig. 3. Reductions in maximal voluntary force (MVF) (A), voluntary activation (B), and 833 
electrically-evoked potentiated twitch (C) and triplet (D) force after cycling exercise. Data 834 
are mean  SD. Reduction from baseline (+P < 0.05, ++P < 0.01). *Greater reduction 835 
compared with ISOTIME (P < 0.05). **Greater reduction compared with ARM-CYC and 836 
ISOTIME (P < 0.01).  837 
 838 
 839 
Fig. 4. Quadriceps neuromuscular activation measured as EMG RMS normalized to Mmax  840 
during cycling in CYC (●), ARM-CYC (□) and ISOTIME (Δ). Data are mean  SD with x-841 
error bars omitted at the end of cycling exercise to improve clarity. *Significant difference: 842 




Fig. 5. Heart rate (A) and blood lactate concentration ([La-]B) (B) during CYC (●), ARM-845 
CYC (□) and ISOTIME (Δ). Data are mean  SD and x-error bars are omitted at the end of 846 
cycling exercise to improve clarity. Measurements at 0 min were taken immediately before 847 
the start of cycling exercise. Significant difference between trials (P < 0.01): **ARM-CYC 848 
vs. CYC and ISOTIME; +CYC and ARM-CYC vs. ISOTIME at the end of cycling; #all trials 849 
at the end of cycling.  850 
 851 
 852 
Fig. 6. Rating of perceived exertion (RPE) and dyspnea during cycling exercise in CYC (●), 853 
ARM-CYC (□) and ISOTIME (Δ). Data are mean  SD and expressed relative to absolute 854 
exercise time (A and B) and when normalized to total cycling exercise duration (C and D). 855 
Measurements at 0 min and 0 %time were taken immediately before the start of cycling 856 
exercise. X-error bars in A and B are omitted at the end of cycling exercise to improve clarity. 857 
Significant difference (P < 0.01): **ARM-CYC vs. CYC and ISOTIME; +CYC and ARM-858 
CYC vs. ISOTIME at the end of cycling.  859 
